Navigation Links
BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/17/2009

$35,267 $9,159 $108,246 $31,003 Related parties 1,370 -- 6,621 -- Total Revenues 36,637 9,159 114,867 31,003 Cost of Goods Sold 17,308 7,676 56,543 26,716 Gross Margin 19,329 1,483 58,324 4,287 Sales and Marketing Expenses 12,532 1,953 36,607 4,377 General and Administration Expenses 3,342 4,276 11,194 8,790 Total Operating Expenses 15,874 6,229 47,801 13,167 Income (Loss) From Operations 3,455 (4,746) 10,523 (8,880) Other Income (Expense): Interest Income 2 179 70 620 Interest (Expense) (765) (446) (3,234) (536) Equity Method Investment Gain (321) (264) 675 (264) Other Income -- 10 -- 81 Total Other Income (Expense) (1,084) (521) (2,489) (99) Income (Loss) Before Provision For Income Taxes 2,371 (5,267) 8,034 (8,979) Provision For Income Taxes (1,406) 15 792 15 Net Income (Loss) $3,777 $(5,282) $7,242 $(8,994) Basic and Fully-Diluted Loss Per Share $0.09 $(0.17) $0.19 $(0.32) Basic and Fully-Diluted Weighted- average Shares Outstanding 40,185 30,708 38,617 28,120 BMP Sunstone Corporation and Subsidiaries Condensed Consolidated Statements of Operation ($ amounts, except per share amounts in thousands) For the Three months For the Twelve months ended December 31, ended Dec
'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. BMP Sunstone to Present at UBS Global Healthcare Services Conference
2. BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
3. BMP Sunstone Receives High Tech Status
4. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
5. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
6. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
7. BMP Sunstone Reports Third Quarter 2008 Financial Results
8. BMP Sunstone Announces Participation in November Investor Conferences
9. BMP Sunstone Announces Participation in September Investor Conference
10. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
11. BMP Sunstone Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Atlanta-based Intellimedix could make a positive ... of Ebola by suggesting a new, computational approach ... Center for Computational Systems Biology have spent years ... uses for existing drugs through systematic repurposing, and ... bout against Ebola. Logo - ...
(Date:10/30/2014)... Global polyvinyl chloride (PVC) demand registered a ... 2008-2009, especially in North America and Europe. However, the ... to a growing trend. , The largest chunk of ... construction segment. In 2013, the key PVC application spheres ... rigid film. Moreover, the PVC was consumed in the ...
(Date:10/30/2014)... October 30, 2014 Rancho BioSciences ... they have manually curated public data source TCGA ... customers. the data is now available for other ... unifies public and internal data sources for their Pharma, ... out of the data that becomes more easily accessible. ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success ... of its fleet of high volume High Pressure Processing (HPP) ... we return to PackExpo this year, which is where we ... said Jeff Williams, CEO at Avure. “Sales of the new ... be meeting the challenges of market demand for higher throughput. ...
Breaking Biology Technology:Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3Rancho BioSciences Manually Curated TCGA Data Sets Available 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3
... Jan. 17 Peptimmune, Inc., a privately,held biotechnology ... close,of $8.2 million of a Series D preferred ... Enterprise Associates, MPM Capital, Hunt Ventures,L.P., Boston Medical ... as,certain other investors, including its Chairman of the ...
... at Cleveland Clinic Brings Extensive Experience, in the Use of ... ... Cardiovascular Disease, ST. LOUIS, Jan. 17 Stereotaxis, Inc. ... as Chief Medical Officer. Dr. Burkhardt was most recently the,Associate ...
... ON, Jan. 17 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... oncology company that identifies,develops and commercializes differentiated products ... a letter from the U.S. Food and Drug,Administration ... Acute Pain,Study (AP5) of AeroLEF(TM) for which FDA ...
Cached Biology Technology:Peptimmune Announces First Close of Series D Private Financing 2Peptimmune Announces First Close of Series D Private Financing 3Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer 2Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer 3YM BioSciences provides update on AeroLEF(TM) clinical development program 2YM BioSciences provides update on AeroLEF(TM) clinical development program 3
(Date:10/30/2014)... 2014 Biological membranes are mainly composed of lipid ... solution ions onto lipid membranes helps clarify functional ... provides a quantitative description of the equilibria between ... and Zbigniew Figaszewski from the University of Bialystok, ... these findings, just published in EPJ E ...
(Date:10/29/2014)... released by unconventional oil and gas production are well ... in the open access journal Environmental Health . ... found. The study is the first to be based ... sites and could be used to supplement official air-quality ... reserves that do not readily flow to the surface. ...
(Date:10/29/2014)... study of its kind to date, researchers have used ... the risk for autism. Joseph Buxbaum, Ph.D., Icahn School ... Daly, Ph.D., Broad Institute of Harvard and MIT, and ... affected children, parents and unrelated people. They identified changes ... the risk for autism spectrum disorder (ASD) – a ...
Breaking Biology News(10 mins):Ion adsorption matter in biology 2Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3
... is hard to fool the brain by providing it with ... driven to a great extent by the amount of energy ... sugars compared to artificial sweeteners. Professor Ivan de Araujo, ... USA, says:,"The consumption of high-calorie beverages is a major contributor ...
... The digestive systems of all animals contain a large number ... provide warmth, shelter and food to a vast range of ... hosts or at least cause no ill effects other than ... have been associated with disease. Among them is Helicobacter ...
... machinery necessary to assemble proteins, the building blocks of ... DNA is first transcribed to messenger RNA in the ... are put in motion to translate the code into ... been demonstrated that the ribosome is far more than ...
Cached Biology News:The brain cannot be fooled by artificial sweeteners 2Getting rid of unwanted visitors 2Global analysis reveals new insights into the ribosome -- with important implications for disease 2Global analysis reveals new insights into the ribosome -- with important implications for disease 3Global analysis reveals new insights into the ribosome -- with important implications for disease 4
... cocktail of 3 siRNAs specifically targeted to ... popular product. The siTrio reagent guarantees you ... target gene when used under standard conditions ... of optimal transfection with one of B-Bridges ...
... This kit #27295 has improved stability and ... improved kit not only has overcome this problem ... first, we have changed the formulation of HRP ... X 1). By this change, the stability of ...
... kit is a complete assay system for ... in human serum or plasma. The assay ... in the IDS 1,25D RIA followed by ... with ready to use reagents, no organic ...
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Biology Products: